S.Korea’s KOTRA to aid domestic pharmaceutical firms in Japan entry
It opens export consultation meeting in Tokyo, in conjunction with the Japan's pharmaceutical Expo
By Apr 18, 2023 (Gmt+09:00)
Deutsche Bank's Korea IB head quits after country head resigns
Macquarie Korea Asset Management confirms two nominees
Hanwha buys S’pore Dyna-Mac’s stake for $73.8 mn from Keppel
Korea's Taeyoung to sell local hotel to speed up debt workout
Meritz leaves door open for an M&A, to stay shareholder friendly
The government-run (South) Korea Trade-Investment Promotion Agency (KOTRA) announced on Tuesday that it will hold an export consultation meeting for Korean companies wishing to enter the Japanese pharmaceutical market in conjunction with the "Convention on Pharmaceutical Ingredients (CPHI) Japan 2023", which will be held from April 19 to 21.
CPHI Japan, which is celebrating its 20th anniversary this year, is Japan's leading pharmaceutical exhibition, with more than 420 exhibitors and over 200 seminars from more than 25 countries in the pharmaceutical manufacturing and distribution industry.
"The Japanese pharmaceutical market is one where local large companies are dominant," said Kim Sam-shik, head of KOTRA's Japan office. "We will actively support Korean companies' business development by quickly disseminating local information necessary for our companies to develop export channels, focusing on generic drugs in high demand locally."
Write to Mi-sun Kang at misunny@hankyung.com
-
Korean SMEsS.Korea’s Shinsegae, KOTRA to help domestic fashion firms for export
Mar 31, 2023 (Gmt+09:00)
1 Min read -
Korean chipmakersS.Korea's KOTRA sends chip investment survey team to Texas
Mar 29, 2023 (Gmt+09:00)
1 Min read